Steven Cohen Vigil Neuroscience, Inc. Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,485,000 shares of VIGL stock, worth $5.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,485,000
Previous 1,485,000
-0.0%
Holding current value
$5.3 Million
Previous $5.94 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
57Shares Held
26.5MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$20.8 Million3.11% of portfolio
-
Northpond Ventures, LLC4.21MShares$15 Million58.42% of portfolio
-
Artal Group S.A. Luxembourg, N41.83MShares$6.53 Million0.46% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$6.47 Million0.22% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.69MShares$6.04 Million0.99% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $101M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...